Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs
نویسندگان
چکیده
Sir while we have no issues with the data presented in the Letter to the Editor [1], we are compelled to give an alternative conclusion. The majority of newborn labs set their own screen cutoffs, and Illinois uses much higher cutoffs than Missouri. It is only meaningful to compare the number of below-cutoff enzyme activity samples with the use of equivalent cutoffs [2–4]. For example, for mucopolysaccharidosis-I, Missouri steadily lowered their cutoff from 20% to 7% of mean iduronidase activity over the past few years [5], whereas Illinois currently uses a much higher cutoff of 14% [6]. With a 7% cutoff the number of screen positives per 100,000 newborns by digital microfluidics fluorescence in Missouri was 43 [5], whereas tandem mass spectrometry (MS/MS) gave 9 in Washington [4,6], 12 in Illinois [6], and 16 in New York [6]. For Pompe disease with equivalent cutoffs [4,6], Missouri reports 52 screen positives per 100,000 [5], Washington 23 [4,6], Illinois 14 [6], and New York 21 [6]. We hypothesize that the lower number of screen positives with MS/MS is due to the high analytical range (not synonymous with dynamic range) of this method compared to fluorometry [7]. Perhaps the clearest evidence that MS/MS performs better than fluorometry comes from a study in Taiwan using an identical set of DBS showing that MS/MS but not fluorometry separates the pseudodeficiency from the Pompe-affected DBS samples (Fig. 1) [8]. This shows that variation due to DBS sampling is not a dominant effect and disproves the statement that the “analytical/dynamic range is irrelevant” [1]. Additionally, there is no correlation seen in one enzymatic activity compared to another for 111,000 DBS tested for iduronidase, -glucosidase, and -galactosidase [9], showing that variation in white cell count or other DBS quality factors are not dominant effects.
منابع مشابه
Response to Gelb et al.: “Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs”
متن کامل
Use of Tandem Mass Spectrometry for Newborn Screening of 6 Lysosomal Storage Disorders in a Korean Population
BACKGROUND We evaluated the performance of multiplex tandem mass spectrometry (MS/MS) in newborn screening for detection of 6 lysosomal storage disorders (LSDs), namely, Niemann-Pick A/B, Krabbe, Gaucher, Fabry, and Pompe diseases and Hurler syndrome. METHODS We revised the conditions and procedures of multiplex enzyme assay for the MS/MS analysis and determined the precision of our enzyme as...
متن کاملNewborn Screening: Are We Ready for It?
The newborn screening (NBS) programme is a complex and organised system consisting of family and personal education, biochemical tests, confi rmatory biochemical and genetic tests, diagnosis, therapy, and patient follow-up. The programme identifi es treatable metabolic disorders, possibly when still asymptomatic, by using dried blood spot (DBS). Over the last 20 years, tandem mass spectrometry ...
متن کاملDevelopment and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders.
BACKGROUND Lysosomal storage disorders (LSDs) comprise more than 40 genetic diseases that result in the accumulation of products that would normally be degraded by lysosomal enzymes. A tandem mass spectrometry (MS/MS)-based method is available for newborn screening for 5 LSDs, and many laboratories are initiating pilot studies to evaluate the incorporation of this method into their screening pa...
متن کاملHigh-throughput assay of 9 lysosomal enzymes for newborn screening.
BACKGROUND There is interest in newborn screening of lysosomal storage diseases (LSDs) because of the availability of treatments. Pilot studies have used tandem mass spectrometry with flow injection of samples to achieve multiplex detection of enzyme products. We report a multiplexing method of 9 enzymatic assays that uses HPLC-tandem mass spectrometry (MS/MS). METHODS The assay of 9 enzymes ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 12 شماره
صفحات -
تاریخ انتشار 2017